neuregulin

Recombinant proteinexperimental

Neuregulins are a family of four structurally related proteins that are part of the EGF family of proteins. These proteins have been shown to have diverse functions in the development of the nervous system and play multiple essential roles in vertebrate embryogenesis including: cardiac development, Schwann cell and oligodendrocyte differentiation, some aspects of neuronal development, as well as the formation of neuromuscular synapses. — Wikipedia

Clinical trial activity

9 trials · 25 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
8
Phase 3
7
Phase 4
0

Earliest trial started Apr 1, 2010 (NCT01131637)

Timeline

2010s

  1. Jan 1, 2010

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2010

    Earliest Phase 3 Sponsor(trial)

  3. Jan 1, 2012

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Multi-specific
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • neuregulin
  • neuregulin-1

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT04468529Phase 3Dec 30, 2020Capital Medical University, Central South University, China Three Gorges University, Yichang, China, Dalian Medical University, Haikou People's Hospital, Hainan People's Hospital, Jiao Tong University, Jilin University, Jinan University, Luoyang Central Hospital, People's Liberation Army of China, Shandong Province Qianfoshan Hospital, Shandong University, Shanghai Putuo District Central Hospital, Shanxi cardiovascular hospital, Shanxi Medical University, Shengjing Hospital, Soochow University, Zensun, Zhengzhou University, Zhongshan Medical University
NCT03388593Phase 3Jul 23, 2018Chinese Academy of Medical Sciences, Zensun
NCT01541202Phase 3Feb 1, 2012Chinese Academy of Medical Sciences, Zensun
NCT01251406Phase 2Jan 1, 2012University of California, San Diego, University of Southern California, Zensun
NCT01439789Phase 3Jun 1, 2011Chinese Academy of Medical Sciences, Zensun
NCT01439893Phase 3Jun 1, 2011Chinese Academy of Medical Sciences, Zensun
NCT01258387Phase 1Dec 1, 2010Acorda Therapeutics
NCT01214096Phase 3Jul 1, 2010Chinese Academy of Medical Sciences, Zensun
NCT01131637Phase 3Apr 1, 2010Chinese Academy of Medical Sciences, Zensun
Showing 9 of 9 trials
Page 1 / 1

Organizations

Research & Development (25)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
ZensunFor profit8822010
Chinese Academy of Medical SciencesAcademic/Hospital6012010
Acorda TherapeuticsFor profit1112010
Capital Medical UniversityAcademic/Hospital1012020
Central South UniversityAcademic/Hospital1012020
China Three Gorges University, Yichang, ChinaAcademic/Hospital1012020
Dalian Medical UniversityAcademic/Hospital1012020
Haikou People's HospitalAcademic/Hospital1012020
Hainan People's HospitalAcademic/Hospital1012020
Jiao Tong UniversityAcademic/Hospital1012020
Jilin UniversityAcademic/Hospital1012020
Jinan UniversityAcademic/Hospital1012020
Luoyang Central HospitalAcademic/Hospital1012020
People's Liberation Army of ChinaGovernment1012020
Shandong Province Qianfoshan HospitalAcademic/Hospital1012020
Shandong UniversityAcademic/Hospital1012020
Shanghai Putuo District Central HospitalAcademic/Hospital1012020
Shanxi cardiovascular hospitalAcademic/Hospital1012020
Shanxi Medical UniversityAcademic/Hospital1012020
Shengjing HospitalAcademic/Hospital1012020
25 organizations
Page 1 / 2